Published in Fed Proc on September 01, 1973
Extracellular ATP: effects, sources and fate. Biochem J (1986) 8.45
Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II). Biochem J (1975) 2.07
Degradation of porstaglandin F2alpha in the human pulmonary circulation. Thorax (1976) 1.34
Prostaglandin inactivation in guinea-pig lung and its inhibition. Br J Pharmacol (1974) 1.32
Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme. Biochem J (1974) 1.13
Isolation and culture of pulmonary endothelial cells. Environ Health Perspect (1984) 1.08
Angiotensin-converting enzyme from rabbit pulmonary particles. Proc Natl Acad Sci U S A (1974) 0.99
The pulmonary endothelial cell. Thorax (1979) 0.90
Metabolism of 125I-labeled lipoproteins by the isolated rat lung. J Cell Biol (1976) 0.82
Angiotensin-converting enzyme: II. Pulmonary endothelial cells in culture. Environ Health Perspect (1980) 0.78
Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest (1983) 4.70
Does diabetes therapy influence the risk of cancer? Diabetologia (2009) 3.66
Structure of Rhodopseudomonas sphaeroides R-26 reaction center. FEBS Lett (1986) 3.28
A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol (1987) 2.63
Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med (1990) 2.25
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia (2007) 2.16
Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II). Biochem J (1975) 2.07
Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet (1979) 2.01
Smoking induces insulin resistance--a potential link with the insulin resistance syndrome. J Intern Med (1993) 2.01
Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell (1976) 1.96
Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1997) 1.73
Phycocyanobilin. Structure and exchange studies by nuclear magnetic resonance and its mode of attachment in phycocyanin. A model for phytochrome. Biochemistry (1968) 1.67
Evidence for lactate production by human adipose tissue in vivo. Diabetologia (1990) 1.63
The organization and myofilament array of insect visceral muscles. J Cell Sci (1966) 1.57
Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia (2007) 1.56
Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun (2001) 1.54
The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia (2008) 1.53
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52
Lipid intolerance in smokers. J Intern Med (1995) 1.48
Angiotensin I: metabolism by plasma membrane of lung. Science (1972) 1.45
A simple radioassay for angiotensin-converting enzyme. Biochem J (1977) 1.44
Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J Lipid Res (1978) 1.43
Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J (2001) 1.41
Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest (1985) 1.40
Isolation and culture of pulmonary artery endothelial cells. Tissue Cell (1978) 1.40
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Effect of laparotomy on plasma renin activity in the rabbit. Nature (1967) 1.34
Relationship of a hiatal hernia to the function of the body of the esophagus and the gastroesophageal junction. J Thorac Cardiovasc Surg (1981) 1.34
Inactivation of bradykinin in the pulmonary circulation. Biochem J (1968) 1.31
Characterization by microdialysis of intracellular glucose level in subcutaneous tissue in humans. Am J Physiol (1988) 1.30
Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med (1991) 1.30
A rapid simple method for the assay of renin in rabbit plasma. Biochem J (1968) 1.30
Counter-regulation of insulin-stimulated glucose transport by catecholamines in the isolated rat adipose cell. J Biol Chem (1984) 1.29
Body fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism (1977) 1.28
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes (2003) 1.28
Regional adipose tissue cellularity in relation to metabolism in young and middle-aged women. Metabolism (1975) 1.28
Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest (1997) 1.27
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25
Exocytosis in the adrenal medulla demonstrated by freeze-etching. Science (1973) 1.25
Metabolism of adenosine 5'-monophosphate during circulation through the lungs. Trans Assoc Am Physicians (1971) 1.25
Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists. Biochim Biophys Acta (1983) 1.25
Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest (1992) 1.24
Endothelial projections as revealed by scanning electron microscopy. Science (1971) 1.24
Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Nature (1978) 1.23
Effect of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci (Lond) (1981) 1.23
Comparison of two methods for determining human adipose cell size. J Lipid Res (1972) 1.23
Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun (2003) 1.23
Regional differences and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest (1979) 1.22
Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1983) 1.22
Pulmonary endothelial cells. Fed Proc (1977) 1.20
A rapid, simple method for isolating pinocytotic vesicles and plasma membrane of lung. Biochim Biophys Acta (1971) 1.19
Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand (1979) 1.18
Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation (1996) 1.17
Glucose uptake in human adipose tissue. Metabolism (1987) 1.15
Characterization of bacterial photosynthetic reaction center crystals from Rhodopseudomonas sphaeroides R-26 by X-ray diffraction. J Mol Biol (1985) 1.14
Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J Biol Chem (1997) 1.14
Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes (1990) 1.14
Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme. Biochem J (1974) 1.13
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism (1990) 1.12
Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J (1999) 1.11
Order! Order! Order in the House! DIAMAP: a road map for European diabetes research. Diabetologia (2008) 1.11
Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes (1999) 1.11
Cellularity in different regions of adipose tissue in young men and women. Metabolism (1972) 1.10
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. Diabetologia (2012) 1.09
Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells. J Lipid Res (1972) 1.08
New substrates for the radioassay of angiotensin converting enzyme of endothelial cells in culture. Tissue Cell (1978) 1.08
[An extensive study gives a hope for better control of type 2 diabetes mellitus]. Lakartidningen (1998) 1.07
Metabolism of [8-L-[14C] phenylalanine]-angiotensin I in the pulmonary circulation. Biochem J (1971) 1.07
AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3). Diabetologia (2010) 1.07
The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb (1994) 1.07
The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis (1997) 1.07
Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes (1987) 1.06
Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia (2004) 1.06
Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med (1999) 1.05
Effect of cell size on lipid synthesis by human adipose tissue in vitro. J Lipid Res (1971) 1.05
Properties of renin substrate in rabbit plasma with a note on its assay. Biochem J (1968) 1.05
The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot Essent Fatty Acids (2005) 1.05
Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol (1994) 1.05
Insulin resistance in fat cells from obese Zucker rats--evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem (2000) 1.04
Alveolar type II cells: studies on the mode of release of lamellar bodies. Tissue Cell (1975) 1.04
Metabolism of angiotensin I in the pulmonary circulation. Biochem J (1970) 1.04
Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia (2012) 1.03
Freeze-etch studies of the plasma membrane of pulmonary endothelial cells. J Cell Biol (1973) 1.03
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis (2008) 1.02
Insulin binding and responsiveness in fat cells from patients with reduced glucose tolerance and type II diabetes. Diabetes (1983) 1.02
Human adipose tissue in culture. VIII. Studies on the insulin-antagonistic effect of glucocorticoids. Metabolism (1979) 1.01
HIV prevalence at reception into Australian prisons, 1991-1997. Med J Aust (1999) 1.01
The toxicity of streptolysin O for beating mammalian heart cells in tissue culture. J Exp Med (1970) 1.00
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes. Diabetes Obes Metab (2011) 1.00
Freeze-fractured lamellar body membranes of the rat lung great alveolar cell. Tissue Cell (1972) 1.00
Dimethylthiourea consumption reflects H2O2 concentrations and severity of acute lung injury. J Appl Physiol (1985) (1985) 0.99
Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals. J Endocrinol Invest (2007) 0.98